Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex

[1]  R. Holder,et al.  Role of 5HT2A and 5HT2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease , 2008, Neurobiology of Aging.

[2]  J. Harvey,et al.  The Time-Course for Up- and Down-Regulation of the Cortical 5-Hydroxytryptamine (5-HT)2A Receptor Density Predicts 5-HT2A Receptor-Mediated Behavior in the Rabbit , 2007, Journal of Pharmacology and Experimental Therapeutics.

[3]  H. Shinno,et al.  Successful treatment with Yi-Gan San for psychosis and sleep disturbance in a patient with dementia with Lewy bodies , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  Stuart C. Sealfon,et al.  Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior , 2007, Neuron.

[5]  Y. Shoyama,et al.  Antipsychotics improve Δ9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice , 2006, Pharmacology Biochemistry and Behavior.

[6]  M. Garcia-Alloza,et al.  Cholinergic–serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer’s disease , 2005, Neuropsychologia.

[7]  H. Arai,et al.  Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies. , 2005, The Journal of clinical psychiatry.

[8]  H. Arai,et al.  A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. , 2005, The Journal of clinical psychiatry.

[9]  G. Tsujimoto,et al.  V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze , 2004, Neuroscience Letters.

[10]  Y. Shoyama,et al.  Anandamide inhibits the DOI-induced head-twitch response in mice , 2004, Psychopharmacology.

[11]  S. Finkel.  Behavioral and psychologic symptoms of dementia. , 2003, Clinics in geriatric medicine.

[12]  C. Seyfried,et al.  EMD 281014, a new selective serotonin 5-HT2A receptor antagonist. , 2003, European journal of pharmacology.

[13]  N. Herrmann,et al.  Role of serotonin in the behavioral and psychological symptoms of dementia. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[14]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[15]  D. Casey.  Tardive dyskinesia and atypical antipsychotic drugs , 1999, Schizophrenia Research.

[16]  A. Sleight,et al.  5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. , 1998, The Journal of pharmacology and experimental therapeutics.

[17]  H. Meltzer,et al.  Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. , 1997, The Journal of pharmacology and experimental therapeutics.

[18]  J. Kehne,et al.  Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. , 1996, The Journal of pharmacology and experimental therapeutics.

[19]  R. Glennon.  Do classical hallucinogens act as 5-HT2 agonists or antagonists? , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[20]  H. Welch,et al.  Survival of outpatients with Alzheimer-type dementia. , 1990, Annals of internal medicine.

[21]  R. Glennon,et al.  Do functional relationships exist between 5-HT1A and 5-HT2 receptors? , 1990, Pharmacology Biochemistry and Behavior.

[22]  W. Drevets,et al.  The Nature of Psychotic Symptoms in Senile Dementia of the Alzheimer Type , 1988, Journal of geriatric psychiatry and neurology.

[23]  S. Corne,et al.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. , 1963, British journal of pharmacology and chemotherapy.

[24]  J. Leysen,et al.  Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors , 2005, Psychopharmacology.

[25]  S. Corne,et al.  A possible correlation between drug-induced hallucinations in man and a behavioural response in mice , 2004, Psychopharmacologia.

[26]  N. Koshikawa,et al.  Effects of Hochu-ekki-to, Yoku-kan-san and Saiko-ka-ryukotsu-borei-to on behavioral despair and acetic acid-induced writhing in mice. , 1998, Methods and findings in experimental and clinical pharmacology.